Clinical trial
The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin During Meal Ingestion in Patients With T2D
NCT03246451 is registered in ClinicalTrials.gov with University Hospital, Gentofte, Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin During Meal Ingestion in Patients With T2D
- Lead sponsor
- University Hospital, Gentofte, Copenhagen
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2017
- Completion date
- December 10, 2017
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.